A Study of QT and QTc Intervals in Patients Administered Immediate Release Paliperidone

PHASE1CompletedINTERVENTIONAL

Enrollment

141

Participants

Timeline

Start Date

February 28, 2005

Study Completion Date

May 31, 2005

Conditions

SchizophreniaSchizoaffective Disorder

Interventions

DRUG

Immediate release (IR) Paliperidone

All Listed Sponsors

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00791349 - A Study of QT and QTc Intervals in Patients Administered Immediate Release Paliperidone | Biotech Hunter | Biotech Hunter